However, the extent of changes in anti- and pro-apoptotic BCL-2 family of proteins in ALL cells with CERS6 knockdown or exogenous expression was not consistent with the differences in cytotoxicity of ABT-737 (Supplemental Fig. S3a). This evidence concerns the gene BCL2 and acute lymphoblastic leukemia.